Webcasts

Wednesday December 8, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET 
Join this webinar to learn how to approach the early stages of drug development and build a long-term plan to advance your drug to market. 

Embarking on the biotech journey: how to build a long-term plan for successful drug development

Tuesday, November 30th, 2021 at 11am EST

Current changes in technology and the impact of the COVID pandemic has greatly accelerated the adoption of RBM methodology and AI/ML assisted risk analysis. 
How are these changing directly impacting your future clinical trials as the industry is reorienting itself around a new normal with regards to monitoring and insights provided by integrated data reviews.

Future of RBM: Aligning monitoring of clinical trials with technological and societal evolution 

Now Available On Demand!

In this webinar, we will explore best practices to optimize your protocol, country and site feasibility strategy by employing a robust multi-channel strategy and a risk management feedback loop to monitor and mitigate risks throughout the project.

Best Practices for Optimizing Your Protocol, Country and Site Feasibility Strategy

Now Available On Demand!

The Next Generation Central Lab is on its way.
Frontage Laboratories Inc explains how it envisions the next-generation central lab and what it will take to get there.

The Next Generation Central Lab

Wednesday November 10, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET

This panel discussion will include an informative conversation among Parexel experts, who will share key considerations in accelerating drug development for rare diseases.

Key Considerations in Accelerating Rare Disease Drug Development

Tuesday, November 9, 2021 11 am EST | 8am PST | 5pm CET | 4pm GMT

Learn how to strengthen patient engagement, improve data quality, and drive greater efficiency in your next clinical trial using decentralized clinical trials tools and eCOA.

Enhancing the patient experience in clinical trials How adaptable DCT models, purpose-built eCOA technology, and intentional engagement strategies can improve retention and increase efficiency

Tuesday, November 2, 2021 at 11am EDT
Get treatments to patients faster  and deliver a better experience for both patients and clinical trial sites. Join IQVIA leaders Jeff Noll and Sara Pawley and learn how IQVIA matches the right connected device for each study protocol to enhance data quality, speed data collection, and accelerate trial outcomes.

Making Every Connection Count- IQVIA Connected Devices powers clinical trials with better data

The way clinical trials are conducted in the European Union will undergo a major change when (EU) No 536/2014 comes into effect in January 2022. But just being compliant with the regulation should not be considered enough – forward-looking organizations are rethinking how technology can play an important part in bringing efficiencies to clinical trials, by reducing failures and driving operational changes beyond compliance.

 New EU (536/2014) Clinical Trial Regulation Set to Attract More Studies and Innovation

***Live: Tuesday, October 26, 2021 at 11 EDT | 8am PDT | 5pm CEST | 4pm BST*** Oracle Health Sciences reveals new research conducted to understand the technology adaptations that were made to clinical trials during the pandemic, the effect of these adaptations, and the impact of these changes on the future of clinical trials.




2021 Research: The Impact of New Clinical Trial Approaches Adopted During Pandemic

Monday, October 25, 2021 at 10am EDT
Attend this webinar to hear about CGP, the latest in onco-innovation for genomic biomarker testing and uncover the role that Illumina and Q2 Solutions are playing in evolving the CGP testing landscape to deliver a localized testing model to support oncology precision medicine clinical trials in Europe. Lastly, the webinar will reveal the updated roadmap of Q2 Solutions’ Edinburgh Genomics laboratory. 